Quadrature Capital Ltd Buys 59,134 Shares of CVS Health Co. (NYSE:CVS)

Quadrature Capital Ltd raised its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 33.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 237,347 shares of the pharmacy operator's stock after purchasing an additional 59,134 shares during the quarter. Quadrature Capital Ltd's holdings in CVS Health were worth $14,915,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Pzena Investment Management LLC boosted its holdings in shares of CVS Health by 132.9% in the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator's stock worth $764,023,000 after acquiring an additional 7,382,931 shares in the last quarter. Hotchkis & Wiley Capital Management LLC boosted its holdings in shares of CVS Health by 34.8% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after acquiring an additional 3,071,613 shares in the last quarter. TOMS Capital Investment Management LP acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $121,987,000. Pathway Financial Advisers LLC boosted its holdings in shares of CVS Health by 5,864.2% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator's stock worth $108,804,000 after acquiring an additional 1,701,331 shares in the last quarter. Finally, State of Michigan Retirement System boosted its holdings in shares of CVS Health by 402.5% in the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator's stock worth $118,455,000 after acquiring an additional 1,606,500 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Down 1.9 %

Shares of CVS traded down $1.09 during trading hours on Thursday, reaching $56.96. The stock had a trading volume of 5,240,580 shares, compared to its average volume of 11,264,739. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The firm has a 50-day moving average of $59.43 and a 200 day moving average of $58.81. The company has a market cap of $71.68 billion, a P/E ratio of 14.73, a P/E/G ratio of 1.01 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 EPS. On average, sell-side analysts expect that CVS Health Co. will post 5.37 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.67%. CVS Health's payout ratio is 67.51%.

Analysts Set New Price Targets

Several research analysts recently weighed in on CVS shares. Truist Financial restated a "buy" rating and issued a $67.00 price objective (down previously from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. StockNews.com cut shares of CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a research report on Tuesday. UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. Finally, Evercore ISI boosted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $70.50.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.